Atlas Trials

Selective Retina Therapy With Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Serous Chorioretinopathy in Korean Patients

Clinical trial NCT03339856 · COMPLETED

Trial details

NCT number
NCT03339856
Sponsor
Kim's Eye Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Central Serous Chorioretinopathy
Start date
2017-01-01
Primary completion
2017-09-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.